Lixisenatide and liraglutide have half-lives of 2.6 h and 12.614.3 h, respectively and are taken once daily
More body fat means more baseline inflammation, which means a lower threshold for disease activation
For decades, nothing worked
This effect proved stronger than common treatments for intracranial hypertension like acetazolamide or topiramate
DVT is the leading cause of pulmonary embolisms, which can cause organ damage or death
"With the approval of the Wegovy pill, patients now have access to a once-daily oral option that delivers weight loss results comparable to injectable Wegovy," said Mike Doustdar, President and CEO of Novo Nordisk, in the company's official statement